Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
 



 Ashmore Group plc

+0700 16 July 2009 

TRADING UPDATE AND ASSETS UNDER MANAGEMENT sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces the following trading update and Assets under Management ("AuM") statement in respect of the period ended 30 June 2009.

Assets under Management

Actual 

Estimated 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External Debt 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

The final quarter of the financial year ended 30 June 2009 saw AuM increase by US$1.4 billion (6%) to US$24.9 billion. This increase comprises investment performance of US$1.9 billion, arising in external debt and local currency, partially offset by net redemptions of US$0.5 billion, solely within the local 

currency theme.

During the financial year ended 30 June 2009, AuM decreased to US$24.9 billion from US$37.5 billion. Investment performance was US$5.1 billion adverseUS$7.1 billion adverse in the first half, and US$2.0 billion positive in the second half. Neredemptions in the period were US$7.4 billion, of which US$5.7 billion arose in the first half of the year across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levels have begun to increase within both public funds and segregated mandates, with net subscriptions achieved in May and June.  

The expansion of the average revenue margin experienced in the first half, principally because of the AuM mix, has been impacted by the timing and make up of external debt and local currency redemptions at the back end of the first half, and through the second half. This has resulted in the average revenue margin for the final quarter returning to the FY07/08 level of 103bps.  

The results for the full year ended 30 June 2009 are in-line with management expectations in the current operating environment. The loss for the year in respect of FX hedge contracts is £42.8 million (6 months to 31 December 2008: £54.2 million)of which £4.5 million (6 months to 31 December 2008: £12.7 million) relates to the mark-to-market of forward contracts to partially hedge FY09/10 management fees. These FY09/10 forward contracts have an aggregate notional value 

of US$120 million, marked at the year end rate of GBP1:1.6458USD. Any future gains or losses on these contracts will arise from deviations from this year end rate.

The Group will announce its results in respect of the financial year to 30 June 2009 on 

15 September 2009. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court133 Fleet Street London EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information, please contact:

Ashmore Group plc

Graeme Dell, Group Finance Director +44 (0)20 3077 6000

Penrose Financial  +44(0)20 7786 4888 

Gay Collins +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFVLDEIELIA
Date   Source Headline
10th Apr 20147:00 amRNSInterim Management Statement
9th Apr 20142:13 pmRNSHolding(s) in Company
8th Apr 20142:47 pmRNSHolding(s) in Company
28th Mar 20145:30 pmRNSDirector/PDMR Shareholding
3rd Mar 20145:48 pmRNSHolding(s) in Company
28th Feb 20147:00 amRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSHalf Yearly Report
24th Feb 20143:14 pmRNSHolding(s) in Company
14th Jan 20147:00 amRNSQ2 AuM Statement
6th Jan 20148:36 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSDirectorate Change
30th Oct 20132:51 pmRNSResult of AGM
29th Oct 20135:00 pmRNSAnnual Information Update
21st Oct 201312:03 pmRNSDirector/PDMR Shareholding
10th Oct 20137:00 amRNSInterim Management Statement
30th Sep 20135:08 pmRNSNotice of AGM
18th Sep 20134:40 pmRNSDirector/PDMR Shareholding
18th Sep 20134:36 pmRNSDirector/PDMR Shareholding
10th Sep 20137:00 amRNSFinal Results
2nd Aug 20134:28 pmRNSHolding(s) in Company
11th Jul 20137:00 amRNSQ4 AuM Statement
9th Jul 20135:43 pmRNSHolding(s) in Company
3rd Jul 20135:03 pmRNSDirector/PDMR Shareholding
24th Jun 20136:28 pmRNSHolding(s) in Company
21st Jun 20133:33 pmRNSHolding(s) in Company
17th Jun 20133:25 pmRNSHolding(s) in Company
13th Jun 20134:05 pmRNSHolding(s) in Company
7th Jun 201311:20 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSCapital Markets Day
11th Apr 20137:00 amRNSInterim Management Statement
25th Mar 20134:30 pmRNSDirector/PDMR Shareholding
21st Mar 201311:36 amRNSHolding(s) in Company
22nd Feb 20134:30 pmRNSDirector/PDMR Shareholding
21st Feb 20137:00 amRNSHalf Yearly Report
19th Feb 20132:06 pmRNSAppointment of Directors
4th Dec 20125:30 pmRNSDirector/PDMR Shareholding
31st Oct 20124:38 pmRNSResult of AGM
26th Oct 20128:48 amRNSAnnual Information Update
11th Oct 20127:00 amRNSInterim Management Statement
1st Oct 20124:24 pmRNSNotice of AGM
21st Sep 20124:20 pmRNSDirector/PDMR Shareholding
11th Sep 20127:00 amRNSFinal Results
12th Jul 20127:00 amRNSTrading Statement
12th Apr 20127:00 amRNSInterim Management Statement
30th Mar 20126:01 pmRNSHolding(s) in Company
30th Mar 20126:00 pmRNSDirector/PDMR Shareholding
27th Feb 20125:10 pmRNSHolding(s) in Company
23rd Feb 20127:00 amRNSHalf Yearly Report
16th Feb 20125:58 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.